Respiratory Syncytial Virus Treatment Market, Global Outlook and Forecast 2022-2028

Code: RW00014830818
Market Monitor Global
Sep-2022
Life Sciences
65 Pages

Respiratory syncytial virus (RSV) is a common virus that infects children and adults; however, children under the age of two tend to have more severe respiratory symptoms. Treatment is mainly supportive care, and most children's disease resolves without complications. Palivizumab for prevention of RSV is an option for high-risk infants and children and can reduce hospitalization and length of stay.
This report contains market size and forecasts of Respiratory Syncytial Virus Treatment in Global, including the following market information:
Global Respiratory Syncytial Virus Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Respiratory Syncytial Virus Treatment market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus Treatment include AstraZeneca, AbbVie, Pfizer, Zydus Pharmaceuticals, Merck and Bausch Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Respiratory Syncytial Virus Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Respiratory Syncytial Virus Treatment Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Respiratory Syncytial Virus Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Respiratory Syncytial Virus Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Global Respiratory Syncytial Virus Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Respiratory Syncytial Virus Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
AbbVie
Pfizer
Zydus Pharmaceuticals
Merck
Bausch Health

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Respiratory Syncytial Virus Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Syncytial Virus Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Syncytial Virus Treatment Overall Market Size
2.1 Global Respiratory Syncytial Virus Treatment Market Size: 2021 VS 2028
2.2 Global Respiratory Syncytial Virus Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Syncytial Virus Treatment Players in Global Market
3.2 Top Global Respiratory Syncytial Virus Treatment Companies Ranked by Revenue
3.3 Global Respiratory Syncytial Virus Treatment Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Syncytial Virus Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Respiratory Syncytial Virus Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Syncytial Virus Treatment Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Syncytial Virus Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Respiratory Syncytial Virus Treatment Market Size Markets, 2021 & 2028
4.1.2 Oral
4.1.3 Injection
4.2 By Type - Global Respiratory Syncytial Virus Treatment Revenue & Forecasts
4.2.1 By Type - Global Respiratory Syncytial Virus Treatment Revenue, 2017-2022
4.2.2 By Type - Global Respiratory Syncytial Virus Treatment Revenue, 2023-2028
4.2.3 By Type - Global Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Syncytial Virus Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Respiratory Syncytial Virus Treatment Revenue & Forecasts
5.2.1 By Application - Global Respiratory Syncytial Virus Treatment Revenue, 2017-2022
5.2.2 By Application - Global Respiratory Syncytial Virus Treatment Revenue, 2023-2028
5.2.3 By Application - Global Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Respiratory Syncytial Virus Treatment Market Size, 2021 & 2028
6.2 By Region - Global Respiratory Syncytial Virus Treatment Revenue & Forecasts
6.2.1 By Region - Global Respiratory Syncytial Virus Treatment Revenue, 2017-2022
6.2.2 By Region - Global Respiratory Syncytial Virus Treatment Revenue, 2023-2028
6.2.3 By Region - Global Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Respiratory Syncytial Virus Treatment Revenue, 2017-2028
6.3.2 US Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.3.3 Canada Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.3.4 Mexico Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Respiratory Syncytial Virus Treatment Revenue, 2017-2028
6.4.2 Germany Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4.3 France Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4.4 U.K. Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4.5 Italy Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4.6 Russia Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.4.8 Benelux Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Respiratory Syncytial Virus Treatment Revenue, 2017-2028
6.5.2 China Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.5.3 Japan Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.5.4 South Korea Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.5.6 India Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Respiratory Syncytial Virus Treatment Revenue, 2017-2028
6.6.2 Brazil Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.6.3 Argentina Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Syncytial Virus Treatment Revenue, 2017-2028
6.7.2 Turkey Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.7.3 Israel Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Respiratory Syncytial Virus Treatment Market Size, 2017-2028
6.7.5 UAE Respiratory Syncytial Virus Treatment Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Respiratory Syncytial Virus Treatment Major Product Offerings
7.1.4 AstraZeneca Respiratory Syncytial Virus Treatment Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 AbbVie
7.2.1 AbbVie Corporate Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Respiratory Syncytial Virus Treatment Major Product Offerings
7.2.4 AbbVie Respiratory Syncytial Virus Treatment Revenue in Global Market (2017-2022)
7.2.5 AbbVie Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Respiratory Syncytial Virus Treatment Major Product Offerings
7.3.4 Pfizer Respiratory Syncytial Virus Treatment Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Zydus Pharmaceuticals
7.4.1 Zydus Pharmaceuticals Corporate Summary
7.4.2 Zydus Pharmaceuticals Business Overview
7.4.3 Zydus Pharmaceuticals Respiratory Syncytial Virus Treatment Major Product Offerings
7.4.4 Zydus Pharmaceuticals Respiratory Syncytial Virus Treatment Revenue in Global Market (2017-2022)
7.4.5 Zydus Pharmaceuticals Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Respiratory Syncytial Virus Treatment Major Product Offerings
7.5.4 Merck Respiratory Syncytial Virus Treatment Revenue in Global Market (2017-2022)
7.5.5 Merck Key News
7.6 Bausch Health
7.6.1 Bausch Health Corporate Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Respiratory Syncytial Virus Treatment Major Product Offerings
7.6.4 Bausch Health Respiratory Syncytial Virus Treatment Revenue in Global Market (2017-2022)
7.6.5 Bausch Health Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Respiratory Syncytial Virus Treatment Market Opportunities & Trends in Global Market
Table 2. Respiratory Syncytial Virus Treatment Market Drivers in Global Market
Table 3. Respiratory Syncytial Virus Treatment Market Restraints in Global Market
Table 4. Key Players of Respiratory Syncytial Virus Treatment in Global Market
Table 5. Top Respiratory Syncytial Virus Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Respiratory Syncytial Virus Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Respiratory Syncytial Virus Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Respiratory Syncytial Virus Treatment Product Type
Table 9. List of Global Tier 1 Respiratory Syncytial Virus Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Respiratory Syncytial Virus Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Respiratory Syncytial Virus Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Respiratory Syncytial Virus Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Respiratory Syncytial Virus Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Respiratory Syncytial Virus Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Respiratory Syncytial Virus Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Respiratory Syncytial Virus Treatment Product Offerings
Table 32. AstraZeneca Respiratory Syncytial Virus Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Respiratory Syncytial Virus Treatment Product Offerings
Table 35. AbbVie Respiratory Syncytial Virus Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Respiratory Syncytial Virus Treatment Product Offerings
Table 38. Pfizer Respiratory Syncytial Virus Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Zydus Pharmaceuticals Corporate Summary
Table 40. Zydus Pharmaceuticals Respiratory Syncytial Virus Treatment Product Offerings
Table 41. Zydus Pharmaceuticals Respiratory Syncytial Virus Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Respiratory Syncytial Virus Treatment Product Offerings
Table 44. Merck Respiratory Syncytial Virus Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bausch Health Corporate Summary
Table 46. Bausch Health Respiratory Syncytial Virus Treatment Product Offerings
Table 47. Bausch Health Respiratory Syncytial Virus Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Respiratory Syncytial Virus Treatment Segment by Type in 2021
Figure 2. Respiratory Syncytial Virus Treatment Segment by Application in 2021
Figure 3. Global Respiratory Syncytial Virus Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Respiratory Syncytial Virus Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Respiratory Syncytial Virus Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Syncytial Virus Treatment Revenue in 2021
Figure 8. By Type - Global Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 12. US Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 24. China Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Respiratory Syncytial Virus Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Respiratory Syncytial Virus Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Respiratory Syncytial Virus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie Respiratory Syncytial Virus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Respiratory Syncytial Virus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Zydus Pharmaceuticals Respiratory Syncytial Virus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Respiratory Syncytial Virus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bausch Health Respiratory Syncytial Virus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE